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A case of StevenseJohnson syndrome in a healthy 58-year-old woman who underwent cataract surgery
under topical anesthesia is reported. General skin erosions developed 2 hours after surgery. The patient's
family doctor diagnosed that she was allergic to seafood. One month later, she underwent phacoemul-
siﬁcation surgery in the other eye. After surgery, she developed StevenseJohnson syndrome with general
skin lesions, erythema nodosa, genital mucosa erosion, oral ulcers, gastritis, and conjunctiva edema. The
symptoms subsided 2 weeks later after immunotherapy. Although nonpreserved anesthesia (2% lido-
caine) has seldom been reported to cause allergic reactions via the intravenous or the intramuscular
route, it is possible that an intracameral injection of 0.2% lidocaine during cataract surgery can induce
StevenseJohnson syndrome. Careful evaluation of the patient's history and proper treatment were rec-
ommended to prevent additional complications.
Copyright © 2014, The Ophthalmologic Society of Taiwan. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Intracameral lidocaine, used as a local anesthetic for phaco-
emulsiﬁcation, is now a standard procedure and widely used for
cataract surgery.1,2 Lidocaine hydrochloride, an amide-type local
anesthetic, is commonly used for facial plastic procedures.3
Although lidocaine is frequently used during these procedures,
adverse drug reactions could still happen, such as hypotension,
bradycardia, urticaria, tissue necrosis, and angioedema, even
administered in a very small dose (Table 1).4 Moreover, most of the
reported reactions are caused by hypersensitivity. In the case of
anaphylactic reaction to lidocaine, early treatment with epineph-
rine, oxygenation, and intravenous ﬂuid resuscitation resulted in
relief of the symptoms.5
StevenseJohnson syndrome is an acute, self-limiting disorder
which affects the skin and two or moremucosal membranes.6 With
the exception of certain idiopathic cases, StevenseJohnson syn-
drome is usually triggered by medications or associated withroprietary or commercial in-
eived for the work described
logy, Chang Gang Memorial
zi City, Chiayi County 61363,
ciety of Taiwan. Published by Elseinfections.6 In this report, we present one patient who developed
StevenseJohnson syndrome which was induced by intracameral
administration of lidocaine during phacoemulsiﬁcation.2. Case report
A 58-year-old woman underwent phacoemulsiﬁcation under
topical anesthesia. Perioperative medications included topical eye
medications: 0.5% proparacaine hydrochloride (Alcaine; S.A. Alcon-
Couvreur N.V., Puurs, Belgium), 1% tropicamide (Mydiracyl 5%;
Alcon-Couvreur), 10% phenylephrine hydrochloride (Wu-Fu, I-Lan
County, Taiwan), and levoﬂoxacin 0.5% (Cravit; Santen, Pharma-
ceutical Co., Ltd., Osaka, Japan). The patient received an intra-
cameral injection of 0.04 mg (0.2 mL, 2% xylocaine, diluted with
0.8 mL balanced salt solution [BSS]) preservative-free lidocaine
hydrochloride (2% xylocaine; AstraZeneca Taiwan, Taipei, Taiwan).
Additionally, ﬂuorometholone 1% (1 mg/mL) (FML; Sinphar Phar-
maceutical Co., Dongshan Township, I-Lan County, Taiwan) and
levoﬂoxacin were both applied BID for 2 weeks. The patient
developed a generalized skin rash with itching 2 hours after cata-
ract surgery. An antihistamine (diphenhydramine (Vena, Panbiotic
labortories, Kaohsiung City, Taiwan) [1 ampoule]) and a steroid
(dexamethasone [8 mg], Standard Chem. & Pharm. Co., Ltd., Tainan
City, Taiwan, intravenous [IV] push) were prescribed, and the
symptoms resolved 5 days later. The oral mucosa, conjunctiva, andvier Taiwan LLC. All rights reserved.
Table 1
Adverse drug reactions caused by lidocaine hydrochloride.
System Common Infrequent
CNS Headache, dizziness,
drowsiness, confusion
Seizures, coma
Cardiovascular Hypotension, bradycardia Arrhythmias, cardiac arrest
Respiratory Dyspnea Bronchospasm, respiratory
depression
Gastrointestinal Nausea, vomiting Metallic taste
Eyes Visual disturbances, local
burning, conjunctival
hyperemia, diplopia
Corneal epithelial changes/
ulceration
Skin Itching, irritation, rash,
paraesthesia
Urticaria, edema, tissue necrosis,
angioedema
Table 2
Common etiologic drugs in StevenseJohnson syndrome.
Drug groups Common drugs
1. Anticonvulsants Phenytoin Carbamazepine
Phenobarbital Ciazepam
2. Antibiotics Cephalosporins
Ampicillin
Amoxicillin
Vancomycin
3. Nonsteroidal
antiinﬂammatory
drugs
Diclofenac
Ketoprofen
Ibuprofen
Sulindac
4. Sulfonamides Cotrimoxazole
Sulfadiazine
Trimethoprim-sulfamethoxazole
Sulfadoxine
5. Miscellaneous Allopurinol
Quinine
Chloroquinine
Metronidazole
Fluconazole
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with minimal signs of inﬂammation.
Onemonth later, the patient underwent surgery in the other eye
with the same procedures and medications. Immediately after the
surgery, she developed a diffuse, erythematous, pruritic full-body
rash that involved the palms of her hands and the soles of her
feet. She also had fever and chest tightness. The patient's eyelids
were edematous and the conjunctivawere chemotic. Antihistamine
(diphenhydramine HCl 30 mg/L ampoule) and steroid injections
(dexamethasone [8 mg], IV push) had only a minimal effect. Two
days later, the skin lesion progressed to erythema nodosa along
with other symptoms, such as genital mucosa erosion, oral ulcers,
and gastritis. As we suspected an adverse drug reaction related to
the patient's cataract surgery, she was referred to an immunologist
(Dr C.-W. Lin). Immunotherapy was arranged immediately. Venous
blood (1 mL) was drawn and fully mixed with 1 mL of 2% lidocaine,
which was intramuscularly injected slowly back into the patient.
Ascorbic acid (200 mg/tab, TID) and prednisolone (5 mg/tab, BID)
were prescribed. The itching and burning sensation subsided 2 days
after the ﬁrst injection. The immunotherapy was performed twice a
week and continued for 3 weeks, until the skin lesions had
resolved. Vision in both eyes was 20/20, and the patient's ocular
examinations were uneventful during this period.3. Discussion
To the best of our knowledge, this is the ﬁrst published report of
StevenseJohnson syndrome after phacoemulsiﬁcation. To deter-
mine the causative agent, we reviewed the patient's medical his-
tory throughout the event. The topical eye medications, which
included 0.5% proparacaine hydrochloride, 1% tropicamide, and 10%
phenylephrine hydrochloride had been used before surgery for the
posterior chamber intraocular lens (PC-IOL) power calculation.
Levoﬂoxacin and ﬂuorometholone 0.1% had been prescribed and
administered after the ﬁrst operation. As no adverse effect had
occurred during these two periods, we could exclude the above-
mentioned medications. Intracamerally injected lidocaine during
the surgery was the only drug which could have induced this
adverse reaction.
Intracameral injection of preservative-free lidocaine is widely
used for local anesthesia and discomfort relief in cataract surgery
with minimal inﬂammation and endothelial cell loss.1,4,7 The
medication normally provides persistent, stable, and satisfactory
pupil dilation for a safe phacoemulsiﬁcation and intraocular lens
implantation in most patients.1,2 However, it may lead to rare but
serious adverse drug reactions, such as StevenseJohnson syn-
drome. In this report, the patient suffered from a skin lesion which
progressed to erythema nodosa along with genital mucosa erosion,
oral ulcers, and gastritis.8StevenseJohnson syndrome is predominantly known as a drug-
induced disease which causes severe adverse cutaneous reactions
which predominantly involve the skin and mucous membranes,
and is considered a medical emergency as it is potentially fatal.9e11
The reactions, which are characterized by extensive necrosis and
detachment of the epidermis, are followed by erosions of the
skin and mucous membranes. The most common causative medi-
cations are sulfonamides, nonsteroidal antiinﬂammatory drugs,
anticonvulsants, and allopurinol (Table 2).10e12,14 The mainstays of
therapy are specialized supportive care, discontinuation of the use
of the suspected inducing drug, and use of intravenous steroid
therapy as the main treatment regimen.10e13 Moreover, in a small
series of patients, immunomodulating agents such as high-dose
intravenous immunoglobulin therapy is effective.12
Supportive management still remains the mainstay of the
treatment for StevenseJohnson syndrome.8 This involves a skilled
clinical assessment, an early identiﬁcation of the etiology, and an
immediate withdrawal of the causative drug. Close monitoring of
ﬂuids and electrolytes is also important for preventing additional
complications.9e12 In this case, we also used immunotherapy
immediately. Venous blood (1mL) from the patient was fully mixed
with 1 mL of 2% lidocaine, which was slowly administered by
intramuscular injection. This method was performed twice a week
and continued for 3 weeks, and the cutaneous lesions and visual
acuity showed obvious improvement after treatment. In this case
report, we provided this safe and easy method to treat this severe
adverse drug reaction.
In conclusion, an intracameral injection of lidocaine, widely
used in phacoemulsiﬁcation, can cause adverse drug reactions.
Deﬁnitive treatment includes prompt identiﬁcation and discon-
tinuation of the possible causative medication, as well as appro-
priate supportive measures. Proper immunotherapy can prevent
further steroid complications and treat the symptoms efﬁciently.
Ophthalmologists who perform cataract surgery should be aware of
this adverse drug reaction and be familiar with its treatment.
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